When a candidate’s brief remarks about supporting transgender youth are turned into a charge that she “backs sex-change surgery for 12‑year‑olds,” you are looking at a textbook example of how a complex medical and policy debate gets flattened into a campaign weapon.
Key Points
- Karishma Manzur, a Democratic U.S. Senate candidate in New Hampshire, has voiced strong support for transgender youth and “transition-related healthcare,” but available quotes do not show her explicitly endorsing gender transition surgery for minors.
- Partisan outlets have framed her comments about a 12‑ or 13‑year‑old exploring gender identity as support for “sex-change procedures” for children, compressing broader “transition care” into “surgery” for political impact.
- In New Hampshire, state law now bans key forms of gender-affirming surgery and medication for minors, meaning that “support” in a policy sense largely concerns whether those restrictions should exist, not whether surgeons should operate on young children.
- Across U.S. medicine, gender-affirming surgeries for minors are extremely rare and currently subject to tightening professional guidance and growing malpractice scrutiny, which further complicates claims that any mainstream candidate wants routine surgeries for children.
The Claim Against Karishma Manzur: What Was Actually Said
The story begins with conservative media coverage of Karishma Manzur, a Bangladeshi‑American scientist running for the U.S. Senate from New Hampshire. A piece in The Gateway Pundit, drawing on reporting from the Washington Free Beacon, accused her of supporting “gender transition surgery for minors” and “sex‑change procedures for 12‑year‑olds.” The article’s central exhibit is a quote from Manzur describing a conversation with a father of a 12‑ or 13‑year‑old who was “in the process of trying to figure out if they’re transitioning.” She then spoke about how difficult adolescence can be, and how particularly delicate it is when a child is exploring identity and possibly transition.
What is missing from the cited passage is any reference to surgery, hormones, puberty blockers, or specific medical interventions. Manzur emphasizes the teenager’s mental health and the privacy and complexity of the situation, framing it as a moment requiring care and support, not listing medical procedures. The same coverage notes she offered “full‑throated support” to the transgender community, and that her campaign priorities include ensuring “transition-related healthcare” is “safe, legal, and accessible like all other essential healthcare services.” That language clearly aligns her with protecting access to some form of transition care—but it does not specify surgery for minors.
From “Transition-Related Healthcare” to “Surgery for Children”
To bridge the gap from Manzur’s comments to the headline accusation, partisan coverage relies on an interpretive move that has become common: treating any defense of “transition-related healthcare” or “medical gender treatments” as synonymous with advocating surgery for minors. In practice, “gender-affirming care” is an umbrella term that usually covers social transition (names, pronouns, clothing), psychological support, and, for some older adolescents, puberty suppression or hormone therapy. Surgery is the least used and most tightly regulated component.
Independent reviews of U.S. practice have found that gender-affirming surgeries for minors are extremely uncommon and concentrated in older teens, often 16–17, with parental consent. A 2024 study from Harvard T.H. Chan School of Public Health reported “little to no utilization” of gender-affirming surgeries among transgender and gender-diverse minors, and higher utilization among cisgender minors and adults for procedures like breast surgery that are not labeled as “gender-affirming.” Fact‑checking organizations similarly note that broad claims about “schools” or “states” providing sex‑change surgeries to children are misinformation; surgeries for minors are rare and governed by strict clinical and legal frameworks.
Against that backdrop, what Manzur appears to be doing is aligning herself with the principle that transgender people—including youth—should have access to transition-related health services, and that these services should be treated as legitimate medical care. Her campaign website lists “transition-related healthcare” alongside reproductive health as care that must remain “safe, legal, and accessible.” The leap from that position to “supports gender transition surgery for minors” is an inference by critics, not a quote or policy proposal from Manzur herself.
New Hampshire’s Legal Environment: What Is Even Possible?
Understanding the stakes in Manzur’s race also requires looking at New Hampshire law. In recent years, the state legislature—under Republican control—has moved to restrict gender-affirming care for minors. House Bill 377 bans the use of puberty blockers and cross‑sex hormones for transgender youth under 18, starting January 1 of the implementation year. A companion bill, House Bill 712, extends existing limits on gender-affirming surgery by explicitly prohibiting minors from undergoing a range of procedures, including “transgender chest surgery” and certain facial surgeries.
Earlier, House Bill 619 targeted “genital gender reassignment surgery” on people under 18, making it a civil offense for providers to perform such surgeries or refer minors out of state for them. While these bills drew strong opposition from many Democrats, some New Hampshire Democrats did vote with Republicans to support bans on surgery for minors, describing such procedures as “a bridge too far” despite otherwise backing transgender rights.
Within this legal architecture, the question for a Senate candidate is not whether surgeons should be allowed to operate on pre‑teen children—New Hampshire already prohibits the main categories of such procedures—but whether those prohibitions are appropriate, and whether federal policy should reinforce or challenge them. A candidate’s support for “transition-related healthcare” thus most plausibly concerns overturning or resisting broad bans on medical care for minors, not advocating routine surgery for 12‑year‑olds.
Medicine’s Shifting Consensus on Pediatric Surgery
The controversy around Manzur’s stance sits inside a larger shift in professional guidance on gender surgeries for adolescents. In early 2026, the American Society of Plastic Surgeons (ASPS), the largest U.S. organization for plastic surgeons, issued a position statement advising that gender-related surgeries be delayed until patients are at least 19 years old. This represented a significant tightening of earlier practice patterns and was widely interpreted as a response to mounting concerns about evidence quality, long‑term outcomes, and legal risk.
Soon after, the American Medical Association signaled support for the principle of postponing surgeries amid “absence of evidence” robust enough to justify adolescent operations. Internationally, some countries—including Finland—have reoriented care for youth toward psychosocial support and away from surgery, explicitly stating that surgery is not offered to minors. At the same time, leading malpractice cases in the United States have underscored the legal stakes: a New York jury’s $2 million award to detransitioner Fox Varian, who underwent a double mastectomy at 16, was the first malpractice verdict against providers of gender-affirming care for minors.
These developments have not ended the debate but have narrowed it substantially. In mainstream medicine today, advocating surgery for younger adolescents is increasingly outside professional guidance, while defending access to psychosocial support, social transition, and sometimes medications remains within the contested but recognized spectrum of care. That distinction matters when evaluating political rhetoric: “supporting transition-related healthcare” does not automatically mean endorsing operations that key medical bodies now advise against for minors.
Political Rhetoric and the Compression of Complex Care
The Manzur episode illustrates how political media compress layered concepts into blunt accusations. A candidate discusses a teenager “in the process of trying to figure out if they’re transitioning,” and stresses mental health and privacy; a campaign website promises to protect “transition-related healthcare” as essential care. From those pieces, critics construct a narrative that she “backs sex‑change procedures for children as young as 12.”
This rhetorical strategy leverages public unease about surgery on minors, even though the underlying quote does not mention surgery and the actual practice of pediatric surgery is rare and regulated. It also sidesteps the far more common and immediate policy question: whether transgender youth should have access to non‑surgical interventions—counseling, puberty blockers, hormones—under clinical guidelines, or whether blanket bans should apply.
Some Democrats in New Hampshire have explicitly broken ranks to oppose surgery for minors, calling it a “bridge too far” and supporting targeted bans even as they defend broader transgender rights. Others, especially in national politics, have champion robust access to gender-affirming care and criticized state-level interference as harmful to youth well‑being. Manzur’s own public record, based on available sources, places her clearly in the camp that wants transition-related care treated as legitimate healthcare and protected from categorical prohibition, but does not provide a direct statement endorsing surgical procedures for young adolescents.
What an Evidence-Driven Reading Supports
For an evidence‑driven reader, three points follow. First, Manzur is a strong supporter of transgender rights and access to transition-related healthcare, and she speaks empathetically about the mental health challenges facing transgender youth and their families. Second, the phrase “transition-related healthcare” is broader than surgery and, in current U.S. practice, is overwhelmingly non‑surgical for minors. Third, there is no direct quote in the sourced material in which Manzur says that 12‑ or 13‑year‑olds should receive surgical gender transition; that claim is an extrapolation by opponents, amplified for political effect.
In an environment where professional bodies themselves are revising guidance on adolescent surgery, and where state law in New Hampshire already restricts key procedures for minors, a careful reading distinguishes between supporting transgender youth and supporting operations on children. The available evidence places Manzur firmly in the former category, with critics working to portray that stance as the latter.
Why This Distinction Matters for Voters
For voters, especially those weighing contested Senate primaries, the distinction is not academic. Policy on transgender youth will continue to evolve; national and state rules on medications and surgeries are likely to be revisited as evidence accumulates and court cases multiply. Understanding what a candidate has actually said—and how those words interact with existing law and medical practice—is essential to judging whether a campaign narrative reflects reality or rhetorical compression.
In Manzur’s case, the record supports a conclusion that she wants transgender youth, including those as young as 12 or 13, to have access to appropriate, professionally guided transition-related care and mental health support. Whether one agrees or disagrees with that position, attributing to her a desire to put pre‑teens into operating rooms goes beyond the evidence.
Sources:
thegatewaypundit.com, youtube.com, nytimes.com, facebook.com, caselaw.findlaw.com, furmanhonick.com, wordonfire.org, economist.com, washingtontimes.com, findlaw.com, reddit.com, nypost.com, livrepository.liverpool.ac.uk, segm.org, karishmaforsenate.com, supremecourt.gov, theatlantic.com, npr.org, hsph.harvard.edu, apnews.com, opa.hhs.gov
